Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that the U.S. Food and […]
Breakthrough Radiology AI Provider Annalise.ai Appoints Proven Global Healthcare Leader as CEO, Officially Launches US Team Following FDA Clearances
annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today […]
Orexo’s Nasal Adrenaline Rescue Medication OX640 Enters Clinical Development
Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces it has successfully initiated the first explorative human clinical study […]
World’s First Chemo Drone Delivery Announced on NHS Birthday
NHS cancer patients will be the first in the world to benefit from chemotherapy delivered […]
Digital Revolution to Bust COVID Backlogs and Deliver More Tailored Care for Patients
People across the country will benefit from faster, more personalised healthcare, following a digital revolution […]
Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer
Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round […]
Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies
Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired […]
VistaPath Raises $4M to Modernize Pathology Labs Using Computer Vision and Artificial Intelligence
VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that […]
PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device
PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing […]
Revolution in Care of Leukaemia as New Treatment Drug Approved for Cancer Patients
The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more